170 results on '"Koch, Michael"'
Search Results
2. PD01-05 ANALYZING THE PERCENTAGE OF POSITIVE 68GA-PSMA-PET/CT SCANS BASED ON PSA RANGES ACROSS DISTINCT INDICATIONS FOR THE SCAN
3. PD17-10 PREDICTING POSITIVE 68GA-PSMA PET/CT SCANS IN BIOCHEMICAL RECURRENCE FOLLOWING PROSTATECTOMY
4. PD27-01 COMPARING MRI AND PSMA PET-CT FOR PREDICTION OF EXTRA PROSTATIC EXTENSION OF PROSTATE CANCER AND SURGICAL GUIDANCE: A PROSPECTIVE TRIAL
5. MP73-05 PIVOTAL STUDY OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) OF LOCALIZED PROSTATE CANCER: 4-YEAR FOLLOW UP
6. PD27-01 PREDICTING EXTRA-PROSTATIC EXTENSION (EPE) FOR SURGICAL GUIDANCE IN PROSTATE CANCER: A COMPARISON OF BIOPSY PATHOLOGY, MULTIPARAMETRIC MRI, AND PSMA-PET
7. Ranking Important Factors for Using Postoperative Chemotherapy in Non-Muscle Invasive Bladder Cancer: Conjoint Analysis Results From the Michigan Urological Surgery Improvement Collaborative (MUSIC)
8. PD63-08 IMPORTANT FACTORS FOR USING POSTOPERATIVE CHEMOTHERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: RESULTS FROM THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (MUSIC)
9. MP46-03 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER: THREE-YEAR FOLLOW-UP
10. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19
11. Barriers to Single-Dose Intravesical Chemotherapy in Nonmuscle Invasive Bladder Cancer—What's the Problem?
12. Reply by Authors
13. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
14. PD32-07 BARRIERS TO SINGLE-DOSE INTRAVESICAL CHEMOTHERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: WHAT'S THE PROBLEM?
15. PD17-02 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER: TWO-YEAR FOLLOW-UP
16. MP49-18 EARLY COMPLICATIONS AS A RESULT OF INDIANA POUCH URINARY DIVERSION: A 7 YEAR EXPERIENCE
17. Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology
18. Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter—Nephroureterectomy and Ureterectomy Specimens
19. MP38-02 UNDERSTANDING THE EFFECT OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF BLADDER CANCER WITH SQUAMOUS CELL HISTOLOGIC VARIANT
20. PD52-03 A MULTICENTER PHASE 1B/2 STUDY OF NEOADJUVANT PEMBROLIZUMAB AND CISPLATIN CHEMOTHERAPY FOR MUSCLE INVASIVE UROTHELIAL CANCER
21. PD19-12 THE CRITICAL IMPORTANCE OF POST HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) PSA AND PSA DENSITY FOLLOWING SURGERY
22. LBA-26 PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER
23. A Prospective Program to Reduce the Clinical Incidence of Clostridium difficile Colitis Infection after Cystectomy
24. Editorial Comment
25. PD15-08 DOES CARCINOMA IN-SITU RESPOND TO CISPLATINUM-BASED NEOADJUVANT CHEMOTHERAPY?: IMPACT ON PATIENT SELECTION FOR ORGAN PRESERVATION
26. LBA21 PHASE 2 CLINICAL TRIAL IN PROSTATE CANCER EVALUATING 68 GA-PSMA-11 DETECTION ON BOTH PREOPERATIVE PET-CT AND IMMEDIATE POSTOPERATIVE SPECIMEN SCANNING
27. LBA20 MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) IN PATIENTS WITH LOCALIZED PROSTATE CANCER: PRELIMINARY RESULTS OF TACT PIVOTAL STUDY
28. MP11-19 TARGETED LYMPH NODE DISSECTION AT RADIOTRACER-AVID SITES IN RECURRENT PROSTATE CANCER: AN EARLY ASSESSMENT OF EFFICACY
29. MP77-13 UTILITY OF POSITRON EMISSION TOMOGRAPHY IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: A COMPARISON OF CARBON-11 ACETATE & 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN RADIOTRACERS
30. MP08-17 IS MAGNETIC RESONANCE IMAGING SENSITIVE ENOUGH FOR PARTIAL GLAND HIGH INTENSITY FOCUSED ULTRASOUND TREATMENT? COMPARING PROSTATE CANCER LESIONS BETWEEN MAGNETIC RESONANCE IMAGING AND PROSTATECTOMY SPECIMENS
31. High Intensity Focused Ultrasound is a Good Treatment Option for Localized Prostate Cancer
32. A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence after Robot-Assisted Radical Prostatectomy with or without a Small Intestinal Submucosa Bladder Neck Sling
33. Robotic versus Open Prostatectomy: End of the Controversy
34. Editorial Comment
35. MP38-13 LONG-TERM 10-YEAR HEALTH-RELATED QUALITY OF LIFE OUTCOMES FOLLOWING RADICAL CYSTECTOMY
36. MP49-02 A STUDY TO EVALUATE THE PROGNOSTIC AND PREDICTIVE UTILITY OF CCP AND HRD ASSAYS AND GENETIC SEQUENCING IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY IN BLADDER CANCER
37. MP56-02 EMPIRIC TREATMENT OF IDENTIFIED CLOSTRIDIUM DIFFICILE CARRIERS AT TIME OF CYSTECTOMY: PRELIMINARY OUTCOMES
38. PD33-03 ADJUSTED CLINICAL OUTCOMES IN PATIENTS WITH SARCOMATOID VARIANT UROTHELIAL CARCINOMA UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE DISEASE
39. MP23-04 IMPACT OF OBESITY ON WOUND COMPLICATIONS FOLLOWING RADICAL PROSTATECTOMY IS MITIGATED BY ROBOTIC TECHNIQUE
40. 5-HT2A and mGlu2/3 receptor interactions
41. Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?
42. MP64-17 LACK OF IMPROVEMENT IN RADICAL CYSTECTOMY OUTCOMES OVER 20 YEARS?
43. MP65-14 INCIDENCE AND RISK FOR CLOSTRIDIUM DIFFICILE INFECTIOUS COLITIS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR BLADDER CANCER
44. PD15-03 RANDOMIZED CLINICAL TRIAL EXAMINING THE RETURN OF URINARY CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH OR WITHOUT A BLADDER NECK SLING
45. MP72-16 MANAGEMENT OF UNRESECTABLE BLADDER CANCER DIAGNOSED AT TIME OF PLANNED CYSTECTOMY
46. MP58-11 DOES SQUAMOUS DIFFERENTIATION PORTEND WORSE OUTCOMES IN UROTHELIAL BLADDER CANCER?
47. SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma
48. Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial
49. Incidence and Risk Factors of Parastomal Hernia in Patients Undergoing Radical Cystectomy and Ileal Conduit Diversion
50. MP77-18 CAN LYMPHOVASCULAR INVASION BE USED AS A SURROGATE FOR LYMPH NODE INVOLVEMENT IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.